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PERSPECTIVES ON DRUGS 
Internet-based drug  
treatment  
This analysis focuses specifically on Internet-based drug 
treatment (IBDT), an intervention that has expanded rapidly in 
Europe over the past decade. It aims to categorise and chart 
the latest developments in the implementation of this mode of 
treatment, including the progress being made in programme 
evaluation and development of a robust evidence base (see 
‘Does Internet-based treatment work?’).
I  What are Internet-based drug treatments?
There are a variety of different websites available that 
provide help for people using licit and illicit substances. 
These range from the purely informational through to fully 
developed treatment programmes. IBDTs can be defined 
as specifically elaborated or adapted, structured drug 
treatment interventions, offered on and communicated over 
the Internet, possibly involving therapist interaction. These 
treatments typically have a defined schedule and time frame; 
consequently, websites that offer a one-time chat with a 
counsellor and self-assessment applications do not constitute 
IBDTs (EMCDDA, 2009). Most IBDTs utilise established 
psychosocial intervention approaches such as cognitive 
behavioural therapy, motivational interviewing and relapse 
prevention theory. 
I  An Internet-based drug treatment typology
One way of differentiating IBDTs is through the level of 
computerised automation they utilise. Following these simple 
Alongside recent changes in prevalence 
levels and patterns of illicit drug use, 
European countries have also seen 
parallel developments in the methods 
used to deliver interventions. With the 
Internet playing such a significant role 
in EU citizens’ lives, especially among 
young people, it is not surprising that 
it is increasingly being recognised as 
a plausible vehicle for delivering drug 
education, prevention and treatment 
programmes. The benefits it offers 
as a mechanism for service delivery 
include its global reach, its potential 
to access user groups not currently 
addressed by specialist drug services, 
and the possibilities offered by providing 
therapeutic input in the ‘comfort’ of 
participants’ homes. 
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criteria, three main types of IBDTs can be identified: self-help 
based programmes, counsellor-guided programmes, and 
complementary treatment programmes.
Self-help based programmes are fully automated online, are 
typically free of charge, and do not contain any automatic 
contact with a counsellor. Generally, participants pass through 
a process of registration, where the data needed to run the 
programme is collected. This information can include personal 
drug consumption, whether the participant’s goal is to stop 
or reduce use, and how they plan to achieve this goal. Once 
they have registered, participants work with virtual tools and 
navigate through the programme on their own. The main 
module is generally a diary where the participant records daily 
drug-related activity. This covers details such as times and 
situations where they experienced cravings, times the drug 
was actually used, the people around them at this time and 
relevant feelings and thoughts. Interactive feedback is then 
generated by an algorithm based on the information entered 
by participants. This feedback aims to help participants to 
gain an insight into their consumption behaviour. It seeks to 
help them recognise and analyse risky or difficult situations 
and identify successful strategies to prevent drug taking. 
Additionally, participants create a personal ‘relapse prevention 
plan’. As add-ons to the programmes, integrated forums are 
sometimes available that allow users to interact with each 
other, thus creating a virtual self-help group. In addition, 
programmes usually offer information about drugs and 
drug use. These programmes generally last between four 
to six weeks. A four-week online self-help programme was 
launched in Hungary in 2010, called Kannabiszpont.hu. It 
had 760 registered users by the end of 2013, and included a 
smartphone application to facilitate access to and use of the 
programme. 
A second type of IBDT programme features scheduled 
online contact with a counsellor in addition to an automated 
programme. Participants in these counsellor-guided 
interventions have regular counselling sessions via the 
Internet or telephone. These interactions may take place in 
one-to-one chat sessions or through message boards. The 
frequency of contact between counsellor and participant can 
vary, as does the duration of these interventions. Counsellor-
assisted programmes often utilise modules and tools that 
are similar to the self-help programmes, such as the personal 
diary and the interactive computer-generated feedback. 
However, unlike the self-help interventions, most but not all 
counsellor-assisted programmes require payment of a fee. 
Programmes like this are currently available, for example, in 
the Netherlands and Germany.
A third category of IBDT (one that has recently been 
introduced across the Netherlands) incorporates both 
automated Internet and face-to-face components. These 
complementary treatment programmes involve participants 
completing assignments online, and also meeting regularly 
in person with a counsellor or other medical practitioner. The 
treatment is individually tailored and utilises different online 
treatment modules, which focus on, for example, giving up 
or reducing alcohol, cannabis or cocaine use. The modules 
contain information, assignments and exercises aimed at 
developing self-control, coping with craving and preventing 
relapse.
All three types of IBDT programme are based on a set 
of psychosocial interventions, geared towards changing 
participants’ drug-use behaviour. These treatment modalities, 
to varying degrees, focus on increasing participants’ 
insight into their drug use, building motivation, managing 
cravings, developing coping strategies and interpersonal 
skills, encouraging lifestyle changes and improving relapse 
prevention strategies.
I A new way to engage clients?
Growth in the availability and use of the Internet has 
fundamentally changed the way drug treatment can be 
offered. It has extended the reach and geographical coverage 
of programmes into areas where physical treatment facilities 
are rare, such as rural communities. IBDTs, in particular 
automated self-help based programmes, are capable of 
treating more users as they are not subject to traditional 
capacity limitations and do not require appointments. This 
allows immediate support, removes waiting times and 
increases services’ potential to reach greater numbers 
of those seeking help than would otherwise be possible. 
Given the absence of face-to-face contact with a medical 
practitioner, however, fully automated self-help based 
programmes are not appropriate for treating all drug problems. 
Nevertheless, these IBDTs do provide valuable assistance 
to individuals whose drug use does not require medical 
assistance and who for whatever reason are unable or 
unwilling to seek traditional treatment. Counsellor-assisted 
programmes have been found to be equally effective 
in establishing the essential components of a working 
counselling relationship, such as building a therapeutic 
alliance (Murphy et al., 2009). While IBDTs cannot completely 
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replace traditional treatment, they can provide some users 
with the opportunity to establish a first contact with support 
services. This initial contact may then lead to face-to-face and 
regular support with a therapist, who might use these new 
tools to extend and augment treatment.
IBDTs in Europe tend to be substance specific, mostly 
addressing young people with cannabis-related problems and 
to a lesser extent with problems associated with the use of 
stimulants, such as cocaine. According to an evaluation report 
from the German IBDT Quit the Shit, for example, the age 
range of the programme participants is between 14 and 48 
years.
IBDT programmes are still a relatively new addition to the 
set of potential health and social responses available for 
treating drug problems in Europe. To date, the literature on 
evaluations of this approach is sparse, although growing 
(see ‘Does Internet-based treatment work?’). In addition, 
a number of limitations have been identified (e.g. Litvin 
et al., 2013). IBDTs may lead to higher attrition rates as 
participants may feel no obligation or pressure to continue 
their treatment due to the anonymity or the automated form 
of treatment delivery. Additionally, the need to pay fees for 
some IBDTs may discourage people, especially younger 
drug users, from accessing these programmes. Fee-paying 
programmes generally have age restrictions (participants 
must be over 18) in place as most web-based payments 
are made through credit cards or may be covered by health 
insurances, which are often under their parents’ names. The 
absence of a guarantee of full anonymity may also be a factor 
in discouraging some users from accessing IBDTs.
I  Conclusions
In the framework of the European Commission’s e-Health 
Action Plan 2012–20, IBDTs are likely to be increasingly 
developed as an adjunct to traditional drug treatment services, 
offering a new way to engage with people experiencing drug 
problems. IBDTs take a set of tested psychosocial techniques 
for helping drug users and integrate them into a set of 
new delivery mechanisms. These web-based interventions 
provide new opportunities for reaching these populations 
and simultaneously expanding available access points to 
professional help in a cost-efficient way. While technologies 
and platforms to access these interventions, such as 
smartphones and tablets, are developing rapidly, anonymity 
and data protection related to transmitting information on 
drug consumption over the Internet remain genuine concerns. 
These issues will need to be fully addressed in any further 
development of these interventions in Europe.
I  Facts and figures 
The global telemedicine market has grown from $9.8 
billion in 2010 to $11.6 billion in 2011, and is expected to 
expand to $27.3 billion in 2016.
70 % of EU citizens use the Internet regularly and high-
speed Internet access through broadband (fixed and 
wireless) covers 99.9 % of EU citizens.
Internet-based drug treatments (IBDTs) can be defined 
as ‘specifically elaborated or adapted, structured and 
scheduled drug treatment interventions, offered in and 
communicated over the web’.
IBDTs have a duration of between 4 and 12 weeks in 
Europe, depending on the programmes.
IBDTs were introduced in 2004 in the EU, appearing 
initially in Germany and the United Kingdom.
Video explaining the internet-based drug treatment, available on the EMCDDA 
website: emcdda.europa.eu/topics/pods/internet-based-drug-treatment
I  Interactive element: video
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In recent years the number of published studies and 
systematic reviews on the effectiveness of Internet-based 
treatment has increased considerably although most of 
the evidence in the addiction field relates to alcohol and 
tobacco treatments. A recent review of the effectiveness 
of Internet-based treatment for addictions concluded 
that although more research is required to determine 
the comparative effectiveness of various Internet-based 
therapies and their components, this mode of delivery is 
effective in achieving positive behavioural changes among 
participants (Gainsbury and Blaszczynsky, 2011).  
 
A meta-analysis of 92 published studies on Internet-based 
therapy further indicated that this modality, on average, is 
as effective or nearly as effective as face-to-face therapy 
(Barak et al., 2008). Several studies have specifically 
investigated the effects of Internet-based treatment for 
problems related to illicit drugs. Results from an Australian 
randomised controlled trial (RCT) on the effectiveness of 
a fully automated Internet-based treatment for cannabis 
use revealed that at week six of the programme the 
experimental group reported significantly fewer days of 
cannabis use during the past month, significantly lower 
past-month quantity of cannabis use, and significantly 
fewer symptoms of cannabis abuse, relative to controls. 
However, cannabis dependence symptoms and past-month 
abstinence did not differ significantly between groups 
(Rooke et al., 2013). Results from a German RCT showed 
that, three months after randomisation, participants in an 
Internet-based treatment with an online counselling group 
showed a significantly stronger reduction in cannabis use 
than the control group who were assigned to a waiting list. 
Additionally, moderate to strong effects were found for the 
reduction of the frequency and the reduction of the quantity 
of cannabis consumed (Tossmann et al., 2011). A meta-
analysis of 10 studies on the effectiveness of this approach 
in reducing the frequency of cannabis use revealed that the 
overall effect size was small but significant post treatment 
(Tait et al., 2013). There is limited evidence available 
regarding interventions addressing the use of other illicit 
substances; however, an RCT on the efficacy of Internet-
based treatment for amphetamine-related problems is 
currently ongoing (Tait et al., 2012).   
 
In summary, there is some evidence to suggest that 
Internet-based treatments can be effective in reducing 
cannabis use in the short term, but there are a range of 
limitations with many of the existing evaluation studies that 
limit the generalisation of results to other populations or to 
other substances. These include small sample sizes, high 
drop-out rates, lack of comparability between studies due 
to non-standardised technologies used and the absence 
of direct behavioural measures (e.g. urine tests) to help 
evaluate outcome measures (Gainsbury and Blaszczynsky, 
2011). In order to address these methodological 
shortcomings, guidelines for designing and reporting 
Internet-based treatment research have recently been 
published to enable results across studies to be replicated, 
extended, compared and contrasted with greater ease and 
clarity (see Proudfoot et al., 2011; Litvin et al., 2013). 
 
Does Internet-based drug treatment work?  
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